Artisan Partners’s Acadia Pharmaceuticals ACAD Stock Holding History

Artisan Partners’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$33.5M	Sell	1,325,134 -6,679	-0.5%	-$147K	0.05%	200
2026 Q1	$29.6M	Buy	+1,331,813	New	+$31.8M	0.05%	260
2022 Q3	–	Sell	-316,293	Closed	-$4.46M	–	314
2022 Q2	$4.46M	Sell	316,293 -910,678	-74%	-$17M	0.01%	303
2022 Q1	$29.7M	Sell	1,226,971 -167,868	-12%	-$4.06M	0.04%	266
2021 Q4	$32.6M	Sell	1,394,839 -38,119	-3%	-$767K	0.04%	277
2021 Q3	$23.8M	Sell	1,432,958 -11,224	-0.8%	-$216K	0.03%	286
2021 Q2	$35.2M	Sell	1,444,182 -113,618	-7%	-$2.56M	0.04%	269
2021 Q1	$40.2M	Buy	1,557,800 +199,130	+15%	+$8.77M	0.05%	268
2020 Q4	$72.6M	Buy	1,358,670 +361,728	+36%	+$18M	0.09%	208
2020 Q3	$41.1M	Sell	996,942 -331,767	-25%	-$14.3M	0.06%	238
2020 Q2	$64.4M	Buy	1,328,709 +64,541	+5%	+$3.1M	0.1%	178
2020 Q1	$53.4M	Sell	1,264,168 -39,372	-3%	-$1.62M	0.11%	172
2019 Q4	$55.8M	Sell	1,303,540 -243,665	-16%	-$10.6M	0.1%	174
2019 Q3	$55.7M	Sell	1,547,205 -7,453	-0.5%	-$226K	0.11%	170
2019 Q2	$41.6M	Buy	1,554,658 +422,829	+37%	+$10.8M	0.08%	191
2019 Q1	$30.4M	Buy	1,131,829 +879,311	+348%	+$20.5M	0.06%	207
2018 Q4	$4.08M	Buy	+252,518	New	+$4.9M	0.01%	252

Other funds holding ACAD

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Artisan Partners's ACAD Position: Q2 2026 in Review

Artisan Partners reduced its Acadia Pharmaceuticals (ACAD) stake by 0.5% in Q2 2026, selling an estimated $147K and leaving 1,325,134 shares worth $33.5M. The position accounts for 0.05% of the portfolio, ranked #200.

Artisan Partners first reported a position in ACAD in Q4 2018 and has held it in 17 quarters since. The position peaked at $72.6M in Q4 2020. 352 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

Artisan Partners held 1,325,134 shares of Acadia Pharmaceuticals worth $33.5M as of Q2 2026.
Artisan Partners sold 6,679 Acadia Pharmaceuticals shares in Q2 2026, an estimated $147K.
Acadia Pharmaceuticals made up 0.05% of Artisan Partners's portfolio in Q2 2026, its #200 holding.
Artisan Partners first reported a position in Acadia Pharmaceuticals in Q4 2018 and has held it in 17 quarters since.
Artisan Partners's Acadia Pharmaceuticals position peaked at $72.6M in Q4 2020.
352 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on Artisan Partners's 13F filing for Q2 2026, filed 13 Aug 2026.